Trial
NCT01915472
A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
IMMU 130
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-19